ACALCULUS LYMPHOEOSINOPHILIC CHOLECYSTITIS ASSOCIATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY

被引：0
|
作者：
CHUNGPARK, M
KIM, B
MARMOLYA, G
KARLINS, N
WOJCIK, E
机构：
[1] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT SURG,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT RADIOL,CLEVELAND,OH 44106
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 1990年 / 114卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1073 / 1075
页数：3
相关论文
共 50 条
  • [1] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    ISHIMITSU, T
    TORISU, M
    SURGERY, 1993, 113 (02) : 192 - 199
  • [2] PULMONARY TOXICITY OF RECOMBINANT INTERLEUKIN-2 PLUS LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    VILLANI, F
    GALIMBERTI, M
    RIZZI, M
    MANZI, R
    EUROPEAN RESPIRATORY JOURNAL, 1993, 6 (06) : 828 - 833
  • [3] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY - ANALYSIS OF A BOLUS INTERLEUKIN-2 AND A CONTINUOUS INFUSION INTERLEUKIN-2 REGIMEN
    CLARK, JW
    SMITH, JW
    STEIS, RG
    URBA, WJ
    CRUM, E
    MILLER, R
    MCKNIGHT, J
    BEMAN, JA
    STEVENSON, HC
    CREEKMORE, S
    STEWART, M
    CONLON, K
    SZNOL, M
    KREMERS, P
    COHEN, P
    LONGO, DL
    CANCER RESEARCH, 1990, 50 (22) : 7343 - 7350
  • [4] LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
    EGGERMONT, AMM
    SUGARBAKER, PH
    CELLULAR IMMUNOLOGY, 1987, 107 (02) : 384 - 394
  • [5] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY FOR GASTROINTESTINAL CANCER
    GUILLOU, P
    ACTA CHIRURGICA SCANDINAVICA, 1989, : 26 - 30
  • [6] INTRAPERITONEAL LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 THERAPY FOR MALIGNANCIES LIMITED TO THE PERITONEAL-CAVITY
    STEIS, RG
    URBA, WJ
    VANDERMOLEN, LA
    BOOKMAN, MA
    SMITH, JW
    CLARK, JW
    MILLER, RL
    CRUM, ED
    BECKNER, SK
    MCKNIGHT, JE
    OZOLS, RF
    STEVENSON, HC
    YOUNG, RC
    LONGO, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) : 1618 - 1629
  • [7] ON THE RELATIVE ROLES OF INTERLEUKIN-2 AND INTERLEUKIN-10 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY
    SPAGNOLI, GC
    JURETIC, A
    SCHULTZTHATER, E
    DELLABONA, P
    FILGUEIRA, L
    HORIG, H
    ZUBER, M
    GAROTTA, G
    HEBERER, M
    CELLULAR IMMUNOLOGY, 1993, 146 (02) : 391 - 405
  • [8] INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY OF NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    BERNSTEIN, ZP
    VAICKUS, L
    FRIEDMAN, N
    GOLDROSEN, MH
    WATANABE, H
    RAHMAN, R
    ARBUCK, SG
    SWEENEY, J
    VESPER, D
    HENDERSON, ED
    ZEFFREN, J
    DENNIN, RA
    LEVITT, D
    FOON, KA
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 141 - 146
  • [9] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER (LAK) CELL THERAPY
    ISHIMITSU, T
    IWASAKI, K
    TORISU, M
    FASEB JOURNAL, 1992, 6 (04): : A1152 - A1152
  • [10] AUGMENTATION OF INSULIN AUTOANTIBODIES FOLLOWING INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER-CELL THERAPY
    BERGSTROM, RW
    ATKINS, MB
    MIER, JW
    PALMER, JP
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1990, 31 (04) : 189 - 193
12345